These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 15501613)
41. Assessment of the relative skin sensitization potency of siloranes and bis-GMA using the local lymph node assay and QSAR predicted potency. Kostoryz EL; Zhu Q; Zhao H; Miller M; Eick JD J Biomed Mater Res A; 2006 Dec; 79(3):684-8. PubMed ID: 16845671 [TBL] [Abstract][Full Text] [Related]
42. Acute and subacute dermal toxicity of Break-Free CLP: a weapons cleaning and maintenance compound. Arfsten DP; Johnson EW; Thitoff AR; Jung AE; Still KR; Brinkley WW; Schaeffer DJ; Jederberg WW; Bobb AJ J Appl Toxicol; 2005; 25(4):318-27. PubMed ID: 16025432 [TBL] [Abstract][Full Text] [Related]
43. Final report of the amended safety assessment of PEG-5, -10, -16, -25, -30, and -40 soy sterol. Int J Toxicol; 2004; 23 Suppl 2():23-47. PubMed ID: 15513823 [TBL] [Abstract][Full Text] [Related]
44. Antimycobacterial potential of the juniper berry essential oil in tap water. Peruč D; Gobin I; Abram M; Broznić D; Svalina T; Štifter S; Staver MM; Tićac B Arh Hig Rada Toksikol; 2018 Mar; 69(1):46-54. PubMed ID: 29604199 [TBL] [Abstract][Full Text] [Related]
45. [Juniper berry oil in diseases of the efferent urinary tract?]. Schilcher H Med Monatsschr Pharm; 1995 Jul; 18(7):198-9. PubMed ID: 7651274 [No Abstract] [Full Text] [Related]
46. Natural oils affect the human skin integrity and the percutaneous penetration of benzoic acid dose-dependently. Nielsen JB Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):575-81. PubMed ID: 16700820 [TBL] [Abstract][Full Text] [Related]
54. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Warheit DB; Hoke RA; Finlay C; Donner EM; Reed KL; Sayes CM Toxicol Lett; 2007 Jul; 171(3):99-110. PubMed ID: 17566673 [TBL] [Abstract][Full Text] [Related]
55. [Application of pure juniper oil on the undamaged skin]. FEDOROVICH OG Vestn Venerol Dermatol; 1945; (3):45-7. PubMed ID: 20280587 [No Abstract] [Full Text] [Related]
56. Amended final report of the safety assessment of dibutyl adipate as used in cosmetics. Andersen A Int J Toxicol; 2006; 25 Suppl 1():129-34. PubMed ID: 16835133 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of elastase activity by essential oils in vitro. Mori M; Ikeda N; Kato Y; Minamino M; Watabe K J Cosmet Dermatol; 2002 Dec; 1(4):183-7. PubMed ID: 17147537 [TBL] [Abstract][Full Text] [Related]
58. Bioassay screening of the essential oil and various extracts from 4 spices medicinal plants. Sharififar F; Moshafi MH; Dehghan-Nudehe G; Ameri A; Alishahi F; Pourhemati A Pak J Pharm Sci; 2009 Jul; 22(3):317-22. PubMed ID: 19553182 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of the safety of mixed tocopheryl phosphates (MTP) -- a formulation of alpha-tocopheryl phosphate plus alpha-di-tocopheryl phosphate. Libinaki R; Ogru E; Gianello R; Bolton L; Geytenbeek S Food Chem Toxicol; 2006 Jul; 44(7):916-32. PubMed ID: 16337325 [TBL] [Abstract][Full Text] [Related]
60. The effect of juniper oil and its derivatives on wound healing. SIPOVSKY PV Biull Eksp Biol Med; 1945; 20(10):36-8. PubMed ID: 21027835 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]